newsfilter
← Latest News
Business Wire·

Equillium to Participate in the Cantor Global Healthcare Conference 2025

EQ

Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the Cantor